Ekaterina Yu. Plotnikova , Gleb I. Kolpinsky , Irina N. Semenchuk , Konstantin A. Krasnov
Abstract
Dietary imbalances and overeating can lead to a common disease today - obesity. Apart from aesthetic considerations, obesity is defined as an excess of adipose tissue, which can lead to serious health problems and predispose to a number of pathological changes and clinical diseases such as diabetes, hypertension, atherosclerosis, coronary heart disease, obstructive sleep apnea, depression, arthropathy weight-related diseases, as well as endometrial and breast cancer. Body weight exceeding the ideal weight for age, sex and height by 20% poses a serious health risk. Bariatric surgery is a comprehensive surgical treatment for morbid obesity when other treatments such as diet, increased physical activity, behavior modification and medications have failed. The two most common procedures used today are sleeve gastrectomy and Roux-en-Y gastric bypass. These procedures have gained popularity recently and are generally considered safe and effective. The article describes common and standard disorders in the digestive system that occur after bariatric surgery. A clinical example of a patient’s history after sleeve gastrectomy is also given, who was not observed and did not carry out the standard necessary postoperative measures.
Key words: bariatric surgery, long-term results, obesity, Roux-en-Y gastric bypass, sleeve gastrectomy, gastroenterological consequences of bariatric surgery, effectiveness, safety, quality of life.
Key words: bariatric surgery, long-term results, obesity, Roux-en-Y gastric bypass, sleeve gastrectomy, gastroenterological consequences of bariatric surgery, effectiveness, safety, quality of life.
About the Author
Ekaterina Yu. Plotnikova 1 , Gleb I. Kolpinsky 1 , Irina N. Semenchuk 2 , Konstantin A. Krasnov 11 Kemerovo State Medical University, Kemerovo, Russia
2 Berezovsk City Hospital named A.M. Nazarenko, Berezovsky, Kemerovo region, Russia
References
1. Gossman H, Butsch WS, Jastreboff AM. Treating the chronic disease of obesity. Med Clin N Am. 2021; 105 (6): 983–1016. DOI: 10.1016/j.mcna.2021.06.005
2. Kawai T, Autieri MV, Scalia R. Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiol Cell Physiol. 2021; 320 (3): C375–C391. DOI: 10.1152/ajpcell.00379.2020
3. Chang SS, Eisenberg D, Zhao L et al. Chemerin activation in human obesity. Obesity (Silver Spring) 2016; 24 (7): 1522–29. DOI: 10.1002/oby.21534
4. Afshin A, Forouzanfar MH, Reitsma MB et al. GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017; 377 (1): 13–27. DOI: 10.1056/NEJMoa1614362
5. Ogden CL, Carroll MD, Lawman HG, et al. Trends in obesity prevalence among children and adolescents in the United States, 1988-1994 through 2013–2014. JAMA. 2016; 315 (21): 2292–99. DOI: 10.1001/jama.2016.6361
6. World Health Organization (WHO) [monograph on the Internet]. Geneva: World Health Organization; 2002. URL: https: //www.who.int/publications/i/item/9241562072
7. Ogden CL, Carroll MD, Kit BK, Flegal KL. Prevalence of childhood and adult obesity in the United States 2011–12. JAMA. 2014; 311 (8): 806–14. DOI: 10.1001/jama.2014.732
8. Finks JF, Dimick JB. An updated National Institutes of Health consensus panel on bariatric surgery. JAMA Surg. 2014; 149 (12): 1329–30. DOI: 10.1001/jamasurg.2014.2443
9. Schauer PR, Bhatt DL, Kirwan JP et al. STAMPEDE Investigators. Bariatric surgery versus intensive medical therapy for diabetes – 5-year outcomes. N Engl J Med. 2017; 376 (7): 641–51. DOI: 10.1056/NEJMoa1600869
10. Adams TD, Davidson LE, Litwin SE et al. Weight and metabolic outcomes 12 years after gastric bypass. N Engl J Med. 2017; 377 (12): 1143–55. DOI: 10.1056/NEJMoa1700459
11. Ikramuddin S, Korner J, Lee WJ et al. Lifestyle intervention and medical management with vs without Roux-en-Y gastric bypass and control of hemoglobin A1c, LDL cholesterol, and systolic blood pressure at 5 years in the Diabetes Surgery Study. JAMA. 2018; 319 (3): 266–78. DOI: 10.1001/jama.2017.20813
12. Arterburn DE, Olsen MK, Smith VA et al. Association between bariatric surgery and long-term survival. JAMA. 2015; 313 (1): 62–70. DOI: 10.1001/jama.2014.16968
13. Aminian A, Zajicheck A, Arterburn DE et al. Association of metabolic surgery with major adverse cardiovascular outcomes in patients with type 2 diabetes and obesity. JAMA. 2019; 322 (13): 1271–82. DOI: 10.1001/jama.2019.14231
14. Aminian A, Al-Kurd A, Wilson R et al. Association of bariatric surgery with major adverse liver and cardiovascular outcomes in patients with biopsy-proven nonalcoholic steatohepatitis. JAMA. 2021; 26 (20): 2031–42. DOI: 10.1001/jama.2021.19569
15. Goldberg I, Yang J, Nie L, Bates AT et al. Safety of bariatric surgery in patients older than 65 years. Surg Obes Relat Dis. 2019; 15 (8): 1380–7. DOI: 10.1016/j.soard.2019.05.016
16. Phillips BT, Shikora SA. The history of metabolic and bariatric surgery: development of standards for patient safety and efficacy. Metabolism. 2018; 79: 97–107. DOI: 10.1016/j.metabol.2017.12.010
17. Buchwald H, Estok R, Fahrbach K, Banel D, Sledge I. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery. 2007; 142 (4): 621–32. DOI: 10.1016/j.surg.2007.07.018
18. Arterburn DE, Telem DA, Kushner RF, Courcoulas AP. Benefits and risks of bariatric surgery in adults: a review. JAMA. 2020; 324 (9): 879–87. DOI: 10.1001/jama.2020.12567
19. American Society of Metabolic and Bariatric Surgery (ASMBS) [Internet]. Newberry, FL: The Society [updated 2022 Jun; cited YYYY Mon D]. Estimate of Bariatric Surgery Numbers, 2011–2020. URL: https: //asmbs.org/resources/estimate-of-bariatric-surgery-numbers
20. Angrisani L, Santonicola A, Iovino P et al. IFSO worldwide survey 2016: primary, endoluminal, and revisional procedures. Obes Surg. 2018; 28 (12): 3783–94. DOI: 10.1007/s11695-018-3450-2
21. Puzziferri N, Roshek TB III, Mayo HG et al. Long-term follow-up after bariatric surgery: a systematic review. JAMA. 2014; 312 (9): 934–42. DOI: 10.1001/jama.2014.10706
22. Lee PC, Dixon J. Bariatric-metabolic surgery: A guide for the primary care physician. Aust Fam Physician. 2017; 46 (7): 465–71.
23. URL: https: //bareoreg.ru/
24. URL: https: //bariatriarf.ru/bareoreg-2020/
25. Grönroos S, Helmiö M, Juuti A, Tiusanen R et al. Effect of Laparoscopic Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass on Weight Loss and Quality of Life at 7 Years in Patients With Morbid Obesity: The SLEEVEPASS Randomized Clinical Trial. JAMA Surg. 2021; 156 (2): 137–46. DOI: 10.1001/jamasurg.2020.5666
26. Sheng B, Truong K, Spitler H et al. The Long-Term Effects of Bariatric Surgery on Type 2 Diabetes Remission, Microvascular and Macrovascular Complications, and Mortality: a Systematic Review and Meta-Analysis. Obes Surg. 2017; 27: 2724–32. DOI: 10.1007/s11695-017-2866-4
27. Crozet J, Pasquer A, Pelascini E, Robert M. Factors influencing bariatric surgery outcomes. J Visc Surg. 2023; 160 (2S): S7-S11. DOI: 10.1016/j.jviscsurg.2022.12.001
28. Nuzzo A, Czernichow S, Hertig A et al. Prevention and treatment of nutritional complications after bariatric surgery. Lancet Gastroenterol Hepatol. 2021; 6 (3): 238–51. DOI: 10.1016/S2468-1253 (20)30331-9
29. Chevallier JM. De la chirurgie de l'obésité a la chirurgie a visée métabolique. Expérience de quinze ans dans un service hospitalier universitaire [From bariatric to metabolic surgery: 15 years experience in a French university hospital]. Bull Acad Natl Med. 2010; 194 (1): 25–36; discussion 36–8. French. DOI: org/10.1016/S0001-4079 (19)32359-3
30. Koch TR, Finelli FC. Postoperative metabolic and nutritional complications of bariatric surgery. Gastroenterol Clin North Am. 2010; 39 (1): 109–24. DOI: 10.1016/j.gtc.2009.12.003
31. Weiss D. Long-term Complications of Bariatric Surgery. JAMA. 2021; 325 (2): 186. DOI: 10.1001/jama.2020.22478. PMID: 33433569
32. Stefura T, Zapała B, Gosiewski T et al. Changes in the Composition of Oral and Intestinal Microbiota After Sleeve Gastrectomy and Roux-En-Y Gastric Bypass and Their Impact on Outcomes of Bariatric Surgery. Obes Surg. 2022; 32 (5): 1439–50. DOI: 10.1007/s11695-022-05954-9
33. Felsenreich DM, Kefurt R, Schermann M et al. Reflux, Sleeve Dilation, and Barrett's Esophagus after Laparoscopic Sleeve Gastrectomy: Long-Term Follow-Up. Obes Surg. 2017; 27 (12): 3092–101. DOI: 10.1007/s11695-017-2748-9
34. Genco A, Soricelli E, Casella G, Maselli R et al. Gastroesophageal reflux disease and Barrett's esophagus after laparoscopic sleeve gastrectomy: a possible, underestimated long-term complication. Surg Obes Relat Dis. 2017; 13 (4): 568–74. DOI: 10.1016/j.soard.2016.11.029
35. Borbély YM, Osterwalder A, Kröll D et al. Diarrhea after bariatric procedures: Diagnosis and therapy. World J Gastroenterol. 2017; 23 (26): 4689–700. DOI: 10.3748/wjg.v23.i26.4689
36. Chaves YD, Destefani AC. Pathophysiology, diagnosis and treatmentof dumping syndrome and its relation to bariatric surgery. Arq Bras Cir Dig. 2016; 29 (Suppl.): 116–9. DOI: 10.1590/0102-6720201600S10028
37. Marsk R, Jonas E, Rasmussen F, Näslund E. Nationwide cohort study of post-gastric bypass hypoglycaemia including 5,040 patients undergoing surgery for obesity in 1986-2006 in Sweden. Diabetologia. 2010; 53 (11): 2307–11. DOI: 10.1007/s00125-010-1798-5
38. Service GJ, Thompson GB, Service FJ et al. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med. 2005; 353 (3): 249–54. DOI: 10.1056/NEJMoa043690
39. Patti ME, McMahon G, Mun EC et al. Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia. 2005; 48 (11): 2236–40. DOI: 10.1007/s00125-005-1933-x
40. Falkén Y, Hellström PM, Holst JJ, Näslund E. Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides. J Clin Endocrinol Metab. 2011; 96 (7): 2227–35. DOI: 10.1210/jc.2010-2876
41. Marathe CS, Rayner CK, Jones KL, Horowitz M. Relationships between gastric emptying, postprandial glycemia, and incretin hormones. Diabetes Care. 2013; 36 (5): 1396–405. DOI: 10.2337/dc12-1609
42. van Beek AP, Emous M, Laville M, Tack J. Dumping syndrome after esophageal, gastric or bariatric surgery: pathophysiology, diagnosis, and management. Obes Rev. 2017; 18 (1): 68–85. DOI: 10.1111/ obr.12467
43. Ikramuddin S, Blackstone RP, Brancatisano A et al. Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trial. JAMA. 2014; 312 (9): 915–22. DOI: 10.1001/jama.2014.10540
44. Borbély YM, Osterwalder A, Kröll D et al. Diarrhea after bariatric procedures: Diagnosis and therapy. World J Gastroenterol. 2017; 23 (26): 4689–700. DOI: 10.3748/wjg.v23.i26.4689
45. McBride CL, Petersen A, Sudan D, Thompson J. Short bowel syndrome following bariatric surgical procedures. Am J Surg. 2006; 192 (6): 828–32. DOI: 10.1016/j.amjsurg.2006.08.052
46. Potoczna N, Harfmann S, Steffen R et al. Bowel habits after bariatric surgery. Obes Surg. 2008; 18 (10): 1287–96. DOI: 10.1007/s11695-008-9456-4
47. Gudmand-Höyer E, Asp NG, Skovbjerg H, Andersen B. Lactose malabsorption after bypass operation for obesity. Scand J Gastroenterol. 1978; 13 (6): 641–7. DOI: 10.3109/00365527809181776
48. Bal BS, Finelli FC, Shope TR, Koch TR. Nutritional deficiencies after bariatric surgery. Nat Rev Endocrinol. 2012; 8 (9): 544–56. DOI: 10.1038/nrendo.2012.48
49. Currò G, Centorrino T, Cogliandolo A et al. A clinical and nutritional comparison of biliopancreatic diversion performed with different common and alimentary channel lengths. Obes Surg. 2015; 25 (1): 45–9. DOI: 10.1007/s11695-014-1347-2
50. Coulthard MG. Oedema in kwashiorkor is caused by hypoalbuminaemia. Paediatr Int Child Health. 2015; 35 (2): 83–9. DOI: 10.1179/2046905514Y.0000000154
51. Shao Y, Ding R, Xu B et al. Alterations of Gut Microbiota After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy in Sprague-Dawley Rats. Obes Surg. 2017; 27 (2): 295–302. DOI: 10.1007/s11695-016-
2297-7
52. Furet JP, Kong LC, Tap J et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes. 2010; 59 (12): 3049–57. DOI: 10.2337/db10-0253
53. Coimbra VOR, Crovesy L, Ribeiro-Alves M et al. Gut Microbiota Profile in Adults Undergoing Bariatric Surgery: A Systematic Review. Nutrients. 2022; 14 (23): 4979. DOI: 10.3390/nu14234979
54. Debédat J, Clément K, Aron-Wisnewsky J. Gut Microbiota Dysbiosis in Human Obesity: Impact of Bariatric Surgery. Curr Obes Rep. 2019; 8 (3): 229–42. DOI: 10.1007/s13679-019-00351-3
55. Rezaie A, Pimentel M, Rao SS. How to Test and Treat Small Intestinal Bacterial Overgrowth: an Evidence-Based Approach. Curr Gastroenterol Rep. 2016; 18 (2): 8. DOI: 10.1007/s11894-015-0482-9
56. Sabaté JM, Jouët P, Harnois F et al. High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis. Obes Surg. 2008; 18 (4): 371–7. DOI: 10.1007/s11695-007-9398-2
57. Madrid AM, Poniachik J, Quera R, Defilippi C. Small intestinal clustered contractions and bacterial overgrowth: a frequent finding in obese patients. Dig Dis Sci. 2011; 56 (1): 155–60. DOI: 10.1007/s10620-010-1239-9
58. Bures J, Cyrany J, Kohoutova D et al. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol. 2010; 16 (24): 2978–90. DOI: 10.3748/wjg.v16.i24.2978
59. Ishida RK, Faintuch J, Paula AM et al. Microbial flora of the stomach after gastric bypass for morbid obesity. Obes Surg. 2007; 17 (6): 752–8. DOI: 10.1007/s11695-007-9139-6
60. Gasbarrini A, Corazza GR, Gasbarrini G et al. 1st Rome H2-Breath Testing Consensus Conference Working Group. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther. 2009; 29: 1–49. DOI: 10.1111/j.1365-2036.2009.03951.x
61. Schwiertz A, Taras D, Schäfer K et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring). 2010; 18 (1): 190–5. DOI: 10.1038/oby.2009.167
62. Jeppesen PB, Mortensen PB. Colonic digestion and absorption of energy from carbohydrates and medium-chain fat in small bowel failure. JPEN J Parenter Enteral Nutr. 1999; 23 (5 Suppl.): S101–5. DOI: 10.1177/014860719902300525
63. Andalib I, Shah H, Bal BS et al. Breath Hydrogen as a Biomarker for Glucose Malabsorption after Roux-en-Y Gastric Bypass Surgery. Dis Markers. 2015; 2015: 102760. DOI: 10.1155/2015/102760
64. Choung RS, Ruff KC, Malhotra A et al. Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture. Aliment Pharmacol Ther. 2011; 33 (9): 1059–67. DOI: 10.1111/j.1365-2036.2011.04625.x
65. Machado JD, Campos CS, Lopes Dah Silva C et al. Intestinal bacterial overgrowth after Roux-en-Y gastric bypass. Obes Surg. 2008; 18 (1): 139–43. DOI: 10.1007/s11695-007-9365-y
66. Sabate JM, Coupaye M, Ledoux S et al. Consequences of Small Intestinal Bacterial Overgrowth in Obese Patients Before and After Bariatric Surgery. Obes Surg. 2017; 27 (3): 599–605. DOI: 10.1007/s11695-016-2343-5
67. Bagdasarian N, Rao K, Malani PN. Diagnosis and treatment of Clostridium difficile in adults: a systematic review. JAMA. 2015; 313 (4): 398–408. DOI: 10.1001/jama.2014.17103
68. Al-Jashaami LS, DuPont HL. Management of Clostridium difficile Infection. Gastroenterol Hepatol (NY). 2016; 12 (10): 609–16.
69. Gérard P. Gut microbiota and obesity. Cell Mol Life Sci. 2016; 73 (1): 147–62. DOI: 10.1007/s00018-015-2061-5
70. Ryan KK, Tremaroli V, Clemmensen C et al. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature. 2014; 509 (7499): 183–8. DOI: 10.1038/nature13135
71. Kohli R, Seeley RJ. Diabetes: the search for mechanisms underlying bariatric surgery. Nat Rev Endocrinol. 2013; 9 (10): 572–4. DOI: 10.1038/nrendo.2013.159
72. Worni M, Guller U, Shah A et al. Cholecystectomy concomitant with laparoscopic gastric bypass: a trend analysis of the nationwide inpatient sample from 2001 to 2008. Obes Surg. 2012; 22 (2): 220–9. DOI: 10.1007/s11695-011-0575-y
73. Borbély Y, Plebani A, Kröll D et al. Exocrine Pancreatic Insufficiency after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2016; 12 (4): 790–4. DOI: 10.1016/j.soard.2015.10.084
74. Friess H, Böhm J, Müller MW et al. Maldigestion after total gastrectomy is associated with pancreatic insufficiency. Am J Gastroenterol. 1996; 91 (2): 341–7.
75. Keller J, Layer P. Human pancreatic exocrine response to nutrients in health and disease. Gut. 2005; 54 (Suppl. 6): vi1-28. DOI: 10.1136/gut.2005.065946
76. Vanderveen KA, Grant CS, Thompson GB et al. Outcomes and quality of life after partial pancreatectomy for noninsulinoma pancreatogenous hypoglycemia from diffuse islet cell disease. Surgery. 2010; 148 (6): 1237–45; discussion 1245–6. DOI: 10.1016/j.surg.2010.09.027
77. Poylin V, Serrot FJ, Madoff RD et al. Obesity and bariatric surgery: a systematic review of associations with defecatory dysfunction. Colorectal Dis. 2011; 13 (6): e92–103. DOI: 10.1111/j.1463-1318.2011.02584.x
78. Sherf Dagan S, Goldenshluger A, Globus I et al. Nutritional Recommendations for Adult Bariatric Surgery Patients: Clinical Practice. Adv Nutr. 2017; 8 (2): 382–94. DOI: 10.3945/an.116.014258
79. Miller K, Hell E, Lang B, Lengauer E. Gallstone formation prophylaxis after gastric restrictive procedures for weight loss: a randomized double-blind placebo-controlled trial. Ann Surg. 2003; 238 (5): 697–702. DOI: 10.1097/01.sla.0000094305.77843.cf
80. Bult MJ, van Dalen T, Muller AF. Surgical treatment of obesity. Eur J Endocrinol. 2008; 158 (2): 135–45. DOI: 10.1530/EJE-07-0145
81. Villegas L, Schneider B, Provost D et al. Is routine cholecystectomy required during laparoscopic gastric bypass? Obes Surg. 2004; 14 (2): 206–11. DOI: 10.1381/096089204322857573
82. Wudel LJ Jr, Wright JK, Debelak JP et al. Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study. J Surg Res. 2002; 102 (1): 50–6. DOI: 10.1006/jsre.2001.6322
83. Swanson CM, Roust LR, Miller K, Madura JA 2nd. What every hospitalist should know about the post-bariatric surgery patient. J Hosp Med. 2012; 7 (2): 156–63. DOI: 10.1002/jhm.939
84. Fearon NM, Kearns EC, Kennedy CA et al. The impact of ursodeoxycholic acid on gallstone disease after bariatric surgery: a meta-analysis of randomized control trials. Surg Obes Relat Dis. 2022; 18 (1): 77–84. DOI: 10.1016/j.soard.2021.10.004
85. Gulinac M, Miteva DG, Peshevska-Sekulovska M et al. Long-term effectiveness, outcomes and complications of bariatric surgery. World J Clin Cases. 2023; 11 (19): 4504–12. DOI: 10.12998/wjcc.v11.i19.
4504
86. Pontiroli AE, Morabito A. Long-term prevention of mortality in morbid obesity through bariatric surgery. a systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Ann Surg. 2011; 253 (3): 484–7. DOI: 10.1097/SLA.0b013e31820d98cb
87. Kwok CS, Pradhan A, Khan MA et al. Bariatric surgery and its impact on cardiovascular disease and mortality: a systematic review and meta-analysis. Int J Cardiol. 2014; 173 (1): 20–8. DOI: 10.1016/j.ijcard.2014.02.026
88. Heber D, Greenway FL, Kaplan LM et al. Endocrine Society. Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2010; 95 (11): 4823–43. DOI: 10.1210/jc.2009-2128
89. Oppert JM, Bellicha A, Roda C et al. Resistance Training and Protein Supplementation Increase Strength After Bariatric Surgery: A Randomized Controlled Trial. Obesity (Silver Spring). 2018; 26 (11): 1709–20. DOI: 10.1002/oby.22317
90. Suhaimi A, Yuliawiratman BS. From Prehab to Rehab: The Functional Restoration of a Bariatric Individual. Bariatric Surgery – From the Non-Surgical Approach to the Post-Surgery Individual Care. 2021; 166 р. DOI: 10.5772/intechopen.94418
For citation:Plotnikova E.Yu., Kolpinsky G.I., Semenchuk I.N., Krasnov K.A. Gastroenterological problems of bariatric surgery. Clinical review for general practice. 2023; 4 (8): 83–92 (In Russ.). DOI: 10.47407/kr2023.4.8.00335
All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.